44th Annual Meeting of the European Society for Blood and Marrow Transplantation
Atara and its collaborating investigator at the University of North Carolina at Chapel Hill will present findings from a comprehensive literature review of the mortality burden of post-transplant lymphoproliferative disorder (PTLD) in patients who have received an allogeneic hematopoietic cell transplant (HCT). The poster will be featured during the upcoming 44th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), which will be held in Lisbon, Portugal, March 18-21, 2018. Details for the presentation are as follows:
Abstract Title: Burden of Post-Transplant Lymphoproliferative Disorder-Mortality After Allogeneic Hematopoietic Cell Transplantation
Poster Session Title: Early Complications / Late Effects & Quality of Life
Presentation Date & Time: Monday, March 19, 2018; 9:00AM - 5:00PM WET
Lead Authors: Aaron Katz, Pharm.D., Ph.D.; Arie Barlev, Pharm.D., M.S.; and AJ Joshi, M.D.
Abstract: A219 http://ebmt2018.org/scientific-programme/
Location: Pavilion 1, Centro de Congressos de Lisboa / Lisbon Congress Centre (LCC)